Summary
A 40-year-old configuration analyst was denied a security clearance under Guideline H (Drug Involvement) due to his admitted marijuana use and substance abuse. The applicant used marijuana at varying frequencies from January 2019 to June 2022. Notably, this included continuous use from June 2020 to June 2022, a period during which he held a security clearance and had access to classified information.
During an April 2020 Personnel Security Interview (PSI), the applicant stated an intention to stop using marijuana, but he continued its use until June 2022. Furthermore, in an August 2022 PSI, he expressed an intention to continue using marijuana in the future.
The denial was based on the applicant's admission of marijuana use while cleared, his stated intent to continue use, and his failure to provide any evidence of mitigation efforts or a commitment to abstain from future drug use. The decision cited disqualifying conditions under Adjudicative Guidelines paragraphs 24(a), 24(c), 24(f), and 24(g).
Why the Applicant Was Denied
- The applicant admitted to using marijuana while holding a security clearance.
- He expressed an intention to continue using marijuana in the future.
- The applicant provided no evidence of efforts to mitigate his drug use or to abstain from future use.
Conditions Referenced
- AG ¶ 24(a)raisedSubstance Misuse
- AG ¶ 24(c)raisedIllegal Possession of a Controlled Substance
- AG ¶ 24(f)raisedIllegal Drug Use While Granted Access to Classified Information
- AG ¶ 24(g)raisedExpressed Intent to Continue Drug Involvement
Key Rule Quoted
“An individual who has been granted access to classified information cannot use illegal drugs under any circumstances.”
Procedural Posture
- SOR issuedApr 6, 2023
- Answer filedApr 11, 2023Applicant chose to evaluate administratively.
- Hearing held—Decision made based on written record.
- Decision dateNov 29, 2023
Cite For
- Denial of Security Clearance Due to Drug Involvement Under Guideline H
- Failure to Mitigate Ongoing Substance Abuse Issues
- Importance of Compliance with Federal Drug Laws for Security Clearance Eligibility